Adage Capital Partners’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$171M Buy
471,833
+129,333
+38% +$44.3M 0.24% 70
2026
Q1
$121M Buy
342,500
+68,208
+25% +$24.3M 0.19% 105
2025
Q4
$89.8M Buy
274,292
+36,600
+15% +$11.6M 0.14% 147
2025
Q3
$67.1M Buy
237,692
+48,828
+26% +$14.2M 0.11% 187
2025
Q2
$52.7M Sell
188,864
-37,004
-16% -$10.5M 0.09% 229
2025
Q1
$70.4M Sell
225,868
-78,859
-26% -$23.3M 0.13% 152
2024
Q4
$79.4M Sell
304,727
-296,935
-49% -$88.1M 0.14% 143
2024
Q3
$194M Buy
601,662
+23,366
+4% +$7.64M 0.34% 48
2024
Q2
$181M Buy
578,296
+159,729
+38% +$46.9M 0.33% 46
2024
Q1
$119M Sell
418,567
-558,017
-57% -$163M 0.22% 87
2023
Q4
$281M Buy
976,584
+254,334
+35% +$69.3M 0.58% 27
2023
Q3
$194M Buy
722,250
+358,137
+98% +$89.4M 0.44% 38
2023
Q2
$80.8M Buy
364,113
+8,357
+2% +$1.94M 0.18% 136
2023
Q1
$86M Sell
355,756
-17,484
-5% -$4.29M 0.19% 129
2022
Q4
$98M Buy
+373,240
New +$100M 0.23% 107
2021
Q4
Sell
-169,238
Closed -$36M 1023
2021
Q3
$36M Buy
169,238
+131,200
+345% +$30.2M 0.07% 280
2021
Q2
$9.27M Sell
38,038
-403,000
-91% -$99.1M 0.02% 718
2021
Q1
$110M Sell
441,038
-62,100
-12% -$14.8M 0.22% 94
2020
Q4
$116M Sell
503,138
-118,029
-19% -$27.2M 0.25% 87
2020
Q3
$158M Sell
621,167
-212,405
-25% -$52.6M 0.4% 49
2020
Q2
$197M Buy
833,572
+213,700
+34% +$48.8M 0.5% 33
2020
Q1
$126M Buy
619,872
+209,325
+51% +$45.7M 0.38% 57
2019
Q4
$99M Buy
410,547
+38,300
+10% +$8.44M 0.24% 107
2019
Q3
$72M Buy
372,247
+293,300
+372% +$56.3M 0.18% 147
2019
Q2
$14.5M Sell
78,947
-134,300
-63% -$24M 0.04% 437
2019
Q1
$40.5M Sell
213,247
-199,808
-48% -$38.2M 0.1% 240
2018
Q4
$80.4M Sell
413,055
-39,700
-9% -$7.75M 0.22% 131
2018
Q3
$93.9M Sell
452,755
-282,300
-38% -$55.6M 0.21% 122
2018
Q2
$136M Buy
735,055
+159,148
+28% +$28.2M 0.31% 75
2018
Q1
$98.2M Sell
575,907
-353,502
-38% -$64.9M 0.23% 116
2017
Q4
$162M Buy
929,409
+113,300
+14% +$20.1M 0.37% 68
2017
Q3
$152M Sell
816,109
-110,900
-12% -$19.6M 0.37% 64
2017
Q2
$160M Sell
927,009
-62,100
-6% -$10.1M 0.39% 53
2017
Q1
$162M Buy
989,109
+72,400
+8% +$12M 0.41% 54
2016
Q4
$134M Sell
916,709
-23,700
-3% -$3.57M 0.37% 70
2016
Q3
$157M Sell
940,409
-144,700
-13% -$24.5M 0.43% 59
2016
Q2
$165M Sell
1,085,109
-7,850
-0.7% -$1.22M 0.45% 62
2016
Q1
$164M Sell
1,092,959
-198,600
-15% -$29.5M 0.44% 61
2015
Q4
$210M Buy
1,291,559
+1,400
+0.1% +$220K 0.55% 42
2015
Q3
$178M Buy
1,290,159
+317,200
+33% +$50M 0.5% 48
2015
Q2
$149M Buy
972,959
+225,000
+30% +$36M 0.37% 66
2015
Q1
$120M Buy
747,959
+163,338
+28% +$25.7M 0.29% 92
2014
Q4
$93.1M Buy
584,621
+331,121
+131% +$51.6M 0.23% 117
2014
Q3
$35.6M Sell
253,500
-466,900
-65% -$61M 0.09% 274
2014
Q2
$85.3M Sell
720,400
-233,500
-24% -$27M 0.22% 127
2014
Q1
$118M Sell
953,900
-413,400
-30% -$50.1M 0.32% 86
2013
Q4
$156M Sell
1,367,300
-704,200
-34% -$80.1M 0.41% 55
2013
Q3
$232M Buy
2,071,500
+1,626,152
+365% +$176M 0.67% 26
2013
Q2
$43.9M Buy
+445,348
New +$46.2M 0.14% 199

Other funds holding AMGN

Adage Capital Partners's AMGN Position: Q2 2026 in Review

Adage Capital Partners increased its Amgen (AMGN) stake by 38% in Q2 2026, buying an estimated $44.3M and bringing the position to 471,833 shares worth $171M. The position accounts for 0.24% of the portfolio, ranked #70.

Adage Capital Partners first reported a position in AMGN in Q2 2013 and has held it in 49 quarters since. The position peaked at $281M in Q4 2023. 3,137 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Adage Capital Partners held 471,833 shares of Amgen worth $171M as of Q2 2026.
  • Adage Capital Partners bought 129,333 Amgen shares in Q2 2026, an estimated $44.3M.
  • Amgen made up 0.24% of Adage Capital Partners's portfolio in Q2 2026, its #70 holding.
  • Adage Capital Partners first reported a position in Amgen in Q2 2013 and has held it in 49 quarters since.
  • Adage Capital Partners's Amgen position peaked at $281M in Q4 2023.
  • 3,137 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Adage Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.